The drug transporter inhibitor, alone or in conjunction with a therapeutic agent, is included in the pharmaceutical composition or dosage form in an amount sufficient to produce the desired effect upon the process or condition, including a variety of conditions and diseases in humans. [0164] For preparing solid compositions such as tablets, the drug transporter inhibitor, alone or in conjunction w